ARCHIVES

FDA Promises No More IND Disruptions Without “Very Valid Reasons,” Nears Agreement With NCI

This article is from The Cancer Letter archive.

Vol. 03 No. 15 | April 15, 1977

Download PDF Visit The Full Archive

Related Articles

Hopkins Investigator Dies In Fall From Denver Hotel Window

May 27, 1977

Patient Advocacy: NBCC Urges Funding For Treatment Of Women Screened In CDC Program

July 17, 1998

Bristol No Longer Needs Yew From Public Lands, Official Says; Will Use Processed Needles

January 29, 1993

NCI Begins Latin American Cancer Research Network

April 10, 2009

NIH establishes new clinical science awards to eventually replace General Clinical Research Centers.

October 21, 2005

FDA Committee Okays High Dose Methotrexate, Mitxantrone In ANL; reverse Breast Cancer Vote

December 11, 1987